Drugs / Montanide ISA 720
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00509158 | Oct 2007 → Oct 2008 | — | Radboud University Medical Center | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 1 | NCT00284973 Background | Jan 2006 → ? | Plasmodium falciparum malaria | Shanghai Wanxing Bio-Pharmaceutical Co. Ltd. | Completed | No outcome recorded |
| Phase 1/2 | NCT01031524 Comparator | Mar → Jul 2004 | Plasmodium falciparum malaria | Swiss Tropical & Public Health Institute | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Montanide Isa 720 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00509158 ↗ |